An Open-Label, Multicentre, Single Arm Phase II Study Of Oral GW572016 As Single Agent Therapy In Subjects With Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin-Containing Regiments

Project: Industry

Participants

Colleges, School and Institutes

Short titleAn Open-Label, Multicentre, Single Arm Phase II Study Of Oral GW572016 As Single Agent Therapy In Subjects With Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin-Containing Regiments
StatusFinished
Effective start/end date1/04/0431/03/07